Pregnenolone sulfate is a significant steroid metabolite and neurosteroid synthesized from cholesterol in various tissues, including the brain, adrenal glands, and liver.
As a neurosteroid, it modulates ion channels, transporters, and enzymes in the nervous system, impacting functions such as memory, learning, and synaptic plasticity.
Unlike its precursor pregnenolone, which diffuses easily through cell membranes due to its lipophilic nature, pregnenolone sulfate, being hydrophilic, relies on specific transporters to enter cells and cross the blood-brain barrier.
This sulfate ester form is involved in both neurological and immunoregulatory functions, exhibiting strong immunosuppressive properties by inducing T cell death and reducing proliferation.
Its levels vary throughout life, with high concentrations at birth, a slight increase during adolescence, and significant rises during pregnancy. Altered levels of pregnenolone sulfate are also observed in conditions like hypothyroidism, hyperthyroidism, and rheumatoid arthritis.
It serves as a crucial precursor in steroid synthesis, can be converted back into pregnenolone, and has therapeutic potential in treating cognitive, mood, and inflammatory disorders due to its unique interaction with ion channels and receptors.
Pregnenolone sulfate is a significant steroid metabolite and a neurosteroid, synthesized from cholesterol and produced from pregnenolone in various tissues including the brain, adrenal glands, and liver.
As a neurosteroid it modulates a variety of ion channels, transporters, and enzymes in the nervous system, impacting functions like memory, learning, and synaptic plasticity.
Pregnenolone sulfate has been upgraded from a modulator to an activator of ion channels, specifically targeting TRP channels, NMDA, and GABAA receptors.
TRP channels are a diverse family of “transient receptor potential” channels that affect ion flow through and between neurons and therefore have a wide range of physiological functions and effects.
Pregnenolone sulfate is formed from pregnenolone by the cytosolic sulfotransferase enzymes SULT2A1, SULT2B1a, SULT2B1b in the adrenal gland, liver, brain, placenta, and other tissues.
Pregnenolone sulfate is not merely a final metabolite for excretion but acts as a precursor for further steroid synthesis.
For example, pregnenolone sulfate can be converted back into pregnenolone, serving as a precursor for further steroid synthesis. When converted back to pregnenolone, it can re-enter the steroid synthesis pathways.
Its concentrations vary throughout life, with high levels at birth that decline to stable levels in adulthood. It plays crucial roles during pregnancy and has altered levels in various diseases.
Due to its hydrophilic nature, pregnenolone sulfate relies on specific transporters to enter cells, facilitating its function as a steroid precursor. [11., 12.]
Pregnenolone, being lipophilic, can diffuse through cell membranes easily. PregS, due to its hydrophilic sulfate moiety, cannot diffuse across membranes as easily and requires transport proteins to cross the blood-brain barrier (BBB) and cell membranes. [11.]
Pregnenolone sulfate levels are high at birth (µM concentrations) and decline to nM levels in adults. During adolescence, these levels increase slightly.
Levels of pregnenolone sulfate rise significantly during pregnancy, peaking at birth.
Altered levels are observed in conditions like hypothyroidism (reduced levels), hyperthyroidism (increased levels), and rheumatoid arthritis (reduced levels).
Pregnenolone acts as a precursor for various steroid hormones like progesterone, estrogens, and androgens.
Pregnenolone sulfate seems to have more neurological affinity, modulating ion channels and neurotransmitter receptors, including NMDA and GABAA receptors, and activating TRP channels (TRPM1 and TRPM3) to influence neuronal excitability and potentially offer therapeutic benefits in neurological conditions. [11.]
Both have immunosuppressive properties via similar pathways, but pregnenolone sulfate also exhibits effects in different pathways including enhanced T cell death and reduced proliferation. [8.]
Pregnenolone sulfate concentrations vary across different brain regions, being highest in the striatum and hypothalamus, while pregnenolone levels are generally measured in serum.
Additionally, while the lipophilic pregnenolone molecule can diffuse through cell membranes easily, the hydrophilic pregnenolone sulfate molecule, cannot diffuse across membranes as easily and requires transport proteins to cross the blood-brain barrier (BBB) and cell membranes.
Pregnenolone sulfate has specific roles in brain function modulation and has been proposed for therapeutic use in treating cognitive and mood disorders due to its interaction with ion channels and receptors, unlike pregnenolone, which is more involved in hormone synthesis pathways.
Pregnenolone sulfate produced in the adrenal glands can be acutely regulated by adrenocorticotropic hormone (ACTH). [28.]
Elevated pregnenolone sulfate levels have been observed in conditions like congenital adrenal hyperplasia, reflecting chronic ACTH stimulation. This makes pregnenolone sulfate a potential marker for poor disease control in such conditions. [28.]
Pregnenolone sulfate plays a significant role in neurological health by modulating inflammation and neuroprotection. [21.]
Specifically, pregnenolone sulfate is involved in neuroprotection and neuroregeneration, particularly in conditions like Alzheimer's disease (AD) and multiple sclerosis (MS).
Pregnenolone and its derivatives, such as pregnenolone sulfate and allopregnanolone, enhance memory, learning, and cognitive functions, while reversing depressive disorders. [21.]
Pregnenolone sulfate enhances neurogenesis and hippocampal plasticity, crucial for cognitive function. [17., 18.]
Pregnenolone sulfate affects acetylcholine release, improving cognitive performance in older animals. [17., 18.] It also increases REM sleep and the growth of new brain cells. [17., 18.]
Pregnenolone and its metabolites such as pregnenolone sulfate act on NMDA, GABA, and cannabinoid receptors in the central nervous system.
NMDA Receptors
Pregnenolone sulfate modulates NMDA receptor activity based on subunit composition, suggesting a role in cognitive enhancement, neuroprotection, mood modulation, and potential addiction therapies. [15., 33.]
GABA Receptors
Pregnenolone sulfate inhibits GABAA receptor function, contrasting with other neurosteroids like allopregnanolone, which enhance it. [32.] This inhibition could promote memory and learning but may worsen symptoms in anxiety-based disorders [2., 32.], particularly in PMDD. [32.]
Cannabinoid Receptors
Pregnenolone acts as an inhibitor of the CB1 receptor, countering THC's effects and protecting against cannabis intoxication. [3., 31.]
Pregnenolone is essential for synthesizing various steroid hormones, including progesterone, estrogen, testosterone, and cortisol.
Because pregnenolone sulfate can be re-converted back to pregnenolone, it can be considered a “precursor pool” in case cholesterol or pregnenolone levels get low. [HARTENECK>>>>>>>>>>
Pregnenolone sulfate, a metabolic derivative of pregnenolone, has been studied for its role in modulating inflammation. In various experiments, pregnenolone sulfate, along with other pregnenolone derivatives, was shown to suppress the secretion of pro-inflammatory cytokines such as TNFα and IL-6 in macrophages and microglial cells. [21.]
Pregnenolone sulfate exhibits stronger immunosuppressive properties compared to pregnenolone. It induces T cell death in a dose-dependent manner, reduces T cell proliferation, and downregulates pro-inflammatory genes. [8.]
Pregnenolone sulfate enhances deep and REM sleep in animal models, showing potential in sleep regulation. [6.]
Pregnenolone supports memory, learning, and cognitive function, providing neuroprotection against neuronal damage. [15., 21., 30., 31., 32.]
Pregnenolone and pregnenolone sulfate reduce bipolar depression and show modest benefits in depressive and manic symptoms in individuals with mood disorders and substance abuse history. [2., 4., 7., 23.]
Lithium, a common therapy used in bipolar disorder, elevates levels of the neurosteroids allopregnanolone and pregnenolone in animals. [4.]
Another small study demonstrated some improvement in irritability in patients with autism spectrum disorder. [9.]
Additional research shows that individuals with HIV on antiretroviral therapy who experience depression have lower levels of neurosteroids including pregnenolone sulfate and DHEA-S compared to those without depressive symptoms. [20.]
These steroids modulate the hypothalamic-pituitary-adrenal (HPA) axis, influencing stress responses and mood regulation. The imbalance of neuroactive steroids, marked by a high cortisol/DHEA-S ratio, is linked to depressive symptoms in this population, suggesting that altered neuroactive steroid metabolism may contribute to depression in ART-treated HIV-infected adults. [20.]
Despite current research available, further studies are recommended to confirm these benefits.
A pilot study investigated pregnenolone as an adjunctive treatment for cognitive and negative symptoms in schizophrenia or schizoaffective disorder.
Pregnenolone and its metabolites, including pregnenolone sulfate, significantly reduced negative symptoms, particularly in affective flattening and alogia, and patients showed greater overall improvement compared to placebo.
While cognitive score improvements were not significant, increases in serum pregnenolone and its metabolite allopregnanolone correlated with better cognitive performance, suggesting potential cognitive benefits.
Pregnenolone was well-tolerated with minimal side effects and did not significantly impact weight, blood pressure, glucose, or other lab parameters.
Its mechanisms may involve neuroprotection, NMDA receptor modulation, and enhancement of GABAergic transmission. Further large-scale studies are needed to confirm these findings.
As a neuroactive steroid, pregnenolone plays a crucial role in mental health, particularly in response to stress. [10.]
Research indicates that pregnenolone and its metabolites including pregnenolone sulfate and allopregnanolone modulate GABAergic activity and the hypothalamic-pituitary-adrenal (HPA) axis, helping restore normal function after stress. [10.]
While these neurosteroids increase during acute stress to aid adaptation, chronic stress and depressive disorders often show reduced levels of these steroids, leading to dysregulated stress responses and altered HPA function. [10.]
Pregnenolone was shown to reduce stress- and cocaine cue-induced craving and anxiety, particularly at the 500 mg dose, and decreases stress-induced autonomic responses (heart rate, systolic, and diastolic blood pressure). [19.]
Pregnenolone sulfate levels are commonly tested in the blood and saliva. Blood samples are collected via venipuncture, while saliva samples may be collected from the comfort of home.
It is important to consult with the ordering provider prior to sample collection, as certain supplements or hormones may affect test results.
Test results should be interpreted within the context of an individual’s medical history, current symptoms, and complete hormone test results.
One laboratory reports the following optimal pregnenolone sulfate levels in saliva: [29.]
Pregnenolone sulfate: 1-23 pg/mL
Another lab reports the following optimal range for pregnenolone in adults in serum: [26.]
Pregnenolone, Adult: 22-237 ng/dL
Clinically, it is uncommon to find elevated pregnenolone sulfate levels outside of excessive pregnenolone supplementation.
Causes of elevated pregnenolone outside of excessive supplementation may include:
Short Term High Stress
Levels of certain neurosteroids can increase short term to accommodate for the effects of high stress. However, long term stress typically causes a decrease in these levels. [10.]
Adrenal Hyperplasia and Adrenal Tumors
Some adrenal tumors become very efficient at producing pregnenolone from cholesterol, which can cause higher levels of pregnenolone sulfate. [22.]
Pregnancy
Pregnenolone and pregnenolone sulfate levels rise in pregnancy. [12., 25.]
Hyperthyroidism
Elevated levels of pregnenolone sulfate levels can be seen in hyperthyroidism. [12.]
Low pregnenolone levels have been associated with conditions such as chronic stress, depression, and may be associated with hormone deficiency, increased inflammation, or neurodegenerative processes [10., 15., 17., 21., 32.]
It can also be seen in hypothyroidism and rheumatoid arthritis. [12.]
Aging may also be a factor in low pregnenolone levels. DHEA, DHEA-S, and pregnenolone levels all decrease with age. [5.]
The decline in pregnenolone is more pronounced in men compared to women. [5.]
When investigating pregnenolone sulfate levels, it's often beneficial to examine other related hormone levels as well. Hormones such as estrogens, progesterone, testosterone, DHEA and DHEAS, may all be considered along with cortisol.
Additionally, practitioners may consider ordering downstream hormone metabolites to see how pregnenolone’s steroid hormone metabolites are further metabolized in the body.
Increasingly, laboratory companies are offering specialized hormone panels for a more comprehensive assessment of steroid hormone production and metabolism.
Click here to compare testing options and order testing for steroid hormones.
[1.] Bracci M, Zingaretti L, Martelli M, et al. Alterations in Pregnenolone and Testosterone Levels in Male Shift Workers. International Journal of Environmental Research and Public Health. 2023;20(4):3195. doi:https://doi.org/10.3390/ijerph20043195
[2.] Brown ES, Park J, Marx CE, Hynan LS, Gardner C, Davila D, Nakamura A, Sunderajan P, Lo A, Holmes T. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Neuropsychopharmacology. 2014 Nov;39(12):2867-73. doi: 10.1038/npp.2014.138. Epub 2014 Jun 11. PMID: 24917198; PMCID: PMC4200497.
[3.] Busquets-Garcia A, Soria-Gómez E, Redon B, Mackenbach Y, Vallée M, Chaouloff F, Varilh M, Ferreira G, Piazza PV, Marsicano G. Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice. Mol Psychiatry. 2017 Nov;22(11):1594-1603. doi: 10.1038/mp.2017.4. Epub 2017 Feb 21. PMID: 28220044; PMCID: PMC5447368.
[4.] Carta, M.G., Bhat, K.M. & Preti, A. GABAergic neuroactive steroids: a new frontier in bipolar disorders?. Behav Brain Funct 8, 61 (2012). https://doi.org/10.1186/1744-9081-8-61
[5.] Chen CY, Wu C, Huang Y, Hung C, Wang L. Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life. Neuropsychiatric Disease and Treatment. 2018;Volume 14:2389-2399. doi:https://doi.org/10.2147/ndt.s176047
[6.] Daftary S, Yon JM, Choi EK, et al. Microtubule associated protein 2 in bipolar depression: Impact of pregnenolone. Journal of affective disorders. 2017;218:49-52. doi:https://doi.org/10.1016/j.jad.2017.04.024
[7.] Darbra S, George O, Bouyer JJ, Piazza PV, Le Moal M, Mayo W. Sleep-wake states and cortical synchronization control by pregnenolone sulfate into the pedunculopontine nucleus. Journal of Neuroscience Research. 2004;76(5):742-747. doi:https://doi.org/10.1002/jnr.20074
[8.] El Hajj, Y., Shahin, T., Dieng, M.M. et al. Pregnenolone sulfate induces transcriptional and immunoregulatory effects on T cells. Sci Rep 14, 6782 (2024). https://doi.org/10.1038/s41598-024-57327-0
[9.] Fung LK, Libove RA, Phillips J, Haddad F, Hardan AY. Brief Report: An Open-Label Study of the Neurosteroid Pregnenolone in Adults with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2014;44(11):2971-2977. doi:https://doi.org/10.1007/s10803-014-2144-4
[10.] Girdler SS, Klatzkin R. Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol Ther. 2007 Oct;116(1):125-39. doi: 10.1016/j.pharmthera.2007.05.006. Epub 2007 May 24. PMID: 17597217; PMCID: PMC2650267.
[11.] Grube M, Hagen P, Jedlitschky G. Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters. Frontiers in Pharmacology. 2018;9. doi:https://doi.org/10.3389/fphar.2018.00354
[12.] Harteneck C. Pregnenolone sulfate: from steroid metabolite to TRP channel ligand. Molecules. 2013 Sep 27;18(10):12012-28. doi: 10.3390/molecules181012012. PMID: 24084011; PMCID: PMC6270300.
[13.] Havlı́kováH, Hill M, Hampl R, L. Stárka. Sex- and Age-Related Changes in Epitestosterone in Relation to Pregnenolone Sulfate and Testosterone in Normal Subjects. The Journal of Clinical Endocrinology & Metabolism. 2002;87(5):2225-2231. doi:https://doi.org/10.1210/jcem.87.5.8499
[14.] Koothirezhi R, Ranganathan S. Postmenopausal Syndrome. [Updated 2023 Apr 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560840/
[15.] Malayev A, Gibbs TT, Farb DH. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br J Pharmacol. 2002 Feb;135(4):901-9. doi: 10.1038/sj.bjp.0704543. PMID: 11861317; PMCID: PMC1573207.
[16.] Marx CE, Keefe RS, Buchanan RW, Hamer RM, Kilts JD, Bradford DW, Strauss JL, Naylor JC, Payne VM, Lieberman JA, Savitz AJ, Leimone LA, Dunn L, Porcu P, Morrow AL, Shampine LJ. Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Neuropsychopharmacology. 2009 Jul;34(8):1885-903. doi: 10.1038/npp.2009.26. Epub 2009 Apr 1. PMID: 19339966; PMCID: PMC3427920.
[17.] Mayo W, Lemaire V, Malaterre J, et al. Pregnenolone sulfate enhances neurogenesis and PSA-NCAM in young and aged hippocampus. Neurobiology of Aging. 2005;26(1):103-114. doi:https://doi.org/10.1016/j.neurobiolaging.2004.03.013
[18.] Mayo W, George O, Darbra S, et al. Individual differences in cognitive aging: implication of pregnenolone sulfate. Progress in Neurobiology. 2003;71(1):43-48. doi:https://doi.org/10.1016/j.pneurobio.2003.09.006
[19.] Milivojevic V, Charron L, Fogelman N, Hermes G, Sinha R. Pregnenolone Reduces Stress-Induced Craving, Anxiety, and Autonomic Arousal in Individuals with Cocaine Use Disorder. Biomolecules. 2022;12(11):1593. doi:https://doi.org/10.3390/biom12111593
[20.] Mukerji SS, Misra V, Lorenz DR, et al. Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy. The journal of infectious diseases (Online University of Chicago Press)/The Journal of infectious diseases. 2020;223(9):1601-1611. doi:https://doi.org/10.1093/infdis/jiaa104
[21.] Murugan S, Jakka P, Namani S, Mujumdar V, Radhakrishnan G. The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation. J Biol Chem. 2019 Mar 22;294(12):4596-4607. doi: 10.1074/jbc.RA118.005543. Epub 2019 Jan 15. PMID: 30647133; PMCID: PMC6433066.
[22.] Nishikawa T, et al. Endocrinol, Japon. Comparative Study of Cyclic AMP-Generation System, Steroid Biosynthesis and Lipid Metabolism in vitro in ACTH Responsive and Unresponsive Adrenal Tumors. 1979;26(1):9-17. Accessed August 1, 2024. https://www.jstage.jst.go.jp/article/endocrj1954/26/1/26_1_9/_pdf/-char/en
[23.] Osuji IJ, Vera-Bolaños E, Carmody TJ, Brown ES. Pregnenolone for cognition and mood in dual diagnosis patients. Psychiatry Res. 2010 Jul 30;178(2):309-12. doi: 10.1016/j.psychres.2009.09.006. Epub 2010 May 21. PMID: 20493557.
[24.] Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocrine reviews. 2004;25(6):947-970. doi:https://doi.org/10.1210/er.2003-0030
[25.] Pennell KD, Woodin MA, Pennell PB. Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry. Steroids. 2015 Mar;95:24-31. doi: 10.1016/j.steroids.2014.12.007. Epub 2014 Dec 23. PMID: 25541057; PMCID: PMC4323841.
[26.] Quest Diagnostics: Test Directory. testdirectory.questdiagnostics.com. Accessed July 31, 2024. https://testdirectory.questdiagnostics.com/test/test-detail/31493/pregnenolone-lcms?cc=MASTER
[27.] Rajfer J. Decreased Testosterone in the Aging Male. Rev Urol. 2003;5(Suppl 1):S1–2. PMCID: PMC1502317.
[28.] Rege J, Nanba AT, Auchus RJ, Ren J, Peng HM, Rainey WE, Turcu AF. Adrenocorticotropin Acutely Regulates Pregnenolone Sulfate Production by the Human Adrenal In Vivo and In Vitro. J Clin Endocrinol Metab. 2018 Jan 1;103(1):320-327. doi: 10.1210/jc.2017-01525. PMID: 29126147; PMCID: PMC5761485.
[29.] Rupa Health. LCMS Saliva Profile Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1I7j4bnY7oT1IrThBO0QyTbnhzhTs6Pzr/view
[30.] Vallée M. Neurosteroids and potential therapeutics: Focus on pregnenolone. The Journal of Steroid Biochemistry and Molecular Biology. 2016;160:78-87. doi:https://doi.org/10.1016/j.jsbmb.2015.09.030
[31.] Vallée M, Vitiello S, Bellocchio L, Hébert-Chatelain E, Monlezun S, Martin-Garcia E, Kasanetz F, Baillie GL, Panin F, Cathala A, Roullot-Lacarrière V, Fabre S, Hurst DP, Lynch DL, Shore DM, Deroche-Gamonet V, Spampinato U, Revest JM, Maldonado R, Reggio PH, Ross RA, Marsicano G, Piazza PV. Pregnenolone can protect the brain from cannabis intoxication. Science. 2014 Jan 3;343(6166):94-8. doi: 10.1126/science.1243985. Erratum in: Science. 2014 Feb 28;343(6174):969. PMID: 24385629; PMCID: PMC4057431.
[32.] Wang M. Neurosteroids and GABA-A Receptor Function. Front Endocrinol (Lausanne). 2011 Oct 4;2:44. doi: 10.3389/fendo.2011.00044. PMID: 22654809; PMCID: PMC3356040.
[33.] Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol. 1991 Sep;40(3):333-6. PMID: 1654510.